Le Lézard
Classified in: Health, Science and technology
Subject: ACC

NORDIC NANOVECTOR - ANNUAL GENERAL MEETING POSTPONED


OSLO, Norway, March 31, 2023 /PRNewswire/ -- The Board of Directors of Nordic Nanovector ASA has decided to postpone the upcoming Annual General Meeting (AGM), which was originally scheduled for 26 April. According to Oslo Børs regulations, the Company must hold its AGM before [date]. A new date for the AGM will be announced as soon as possible.

Meanwhile, the Company continues to work with potential strategic transactions or partnership that will deliver value for all stakeholders, and will come back with more information in due course.

For further information, please contact:

IR enquiries

Ludvik Sandnes, Interim CEO & CFO
Cell: +47 907 43 017
Email: [email protected]

Media Enquiries

Mark Swallow/Frazer Hall (MEDiSTRAVA Consulting)
Tel: +44 203 928 6900
Email: [email protected]

About Nordic Nanovector:

Nordic Nanovector is committed to develop and deliver innovative therapies to patients to address major unmet medical needs and advance cancer care. Further information can be found at www.nordicnanovector.com.

 

The following files are available for download:

https://mb.cision.com/Main/9819/3744491/1957730.pdf

230330 PRESS RELEASE AGM POSTPONED

 

SOURCE Nordic Nanovector


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: